Fused ring derivative as A2A receptor inhibitor
US11312715B2 · kind B2 · utility
0Cited by
5References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 27, 2018 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Nov 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and an application of the compound or slat in preparation of drugs for treating diseases related to an A2A receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.